Who makes beta-glucan MM-10-001?

beta-glucan MM-10-001 is developed by City of Hope Medical Center.

What development phase is beta-glucan MM-10-001 in?

beta-glucan MM-10-001 is in Phase 1.

Last reviewed 2026-04-19 · How we verify

beta-glucan MM-10-001

City of Hope Medical Center · Phase 1 active Biologic

At a glance

Generic name	beta-glucan MM-10-001
Sponsor	City of Hope Medical Center
Modality	Biologic
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Beta-Glucan in Treating Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (PHASE1)
Dose Escalation Safety Study of MM-10-001 in Healthy Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

beta-glucan MM-10-001 CI brief — competitive landscape report
beta-glucan MM-10-001 updates RSS · CI watch RSS
City of Hope Medical Center portfolio CI